Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperlipidemia. What to do when life-style changes aren't enough.

W L Peters1

  • 1HealthMark Centers Inc, Englewood, CO 80111.

Postgraduate Medicine
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Very long baseline interferometric observations made with an orbiting radio telescope.

Science (New York, N.Y.)·1986
Same author

The evaluation and treatment of hypercholesterolemia in primary care practice.

Journal of general internal medicine·1986
Same author

[Ephemeroptera-host list for associated organisms (author's transl)].

Annales de parasitologie humaine et comparee·1976
Same author

The radiographic categorization of coal workers' pneumoconiosis by lay readers.

Environmental research·1973

Most lipid disorders, including hypercholesterolemia and hypertriglyceridemia, require lifestyle changes before medication. Treatment choice and combination therapy depend on clinical factors and patient monitoring for effective lipid management.

Area of Science:

  • Internal Medicine
  • Cardiology
  • Endocrinology

Background:

  • Lipid abnormalities are common in primary care.
  • Key categories include hypercholesterolemia, combined hyperlipidemia, and hypertriglyceridemia.

Purpose of the Study:

  • To outline a practical approach to managing common lipid abnormalities in primary care.
  • To guide drug selection and therapy based on clinical evidence and patient factors.

Main Methods:

  • Review of lipid disorder classifications and treatment guidelines.
  • Emphasis on stepwise management: lifestyle modification followed by pharmacotherapy.
  • Consideration of drug efficacy, safety, and impact on lipid profiles.

Main Results:

Related Experiment Videos

  • Dietary and lifestyle changes are the initial recommended treatment for 3–6 months.
  • Drug selection should prioritize clinical efficacy, long-term safety, and effects on LDL, HDL, and triglycerides.
  • Combination therapy is frequently needed, particularly for genetic hyperlipidemia or symptomatic coronary artery disease.

Conclusions:

  • A structured approach to lipid management is essential in primary care.
  • Patient education on medication adherence, side effects, and monitoring is crucial for successful outcomes.
  • Tailored therapeutic strategies, including combination therapy, are vital for achieving lipid treatment goals.